Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.44 |
| ▸ | HRH2 | P25021 | 1/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.37 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13999897 | 0.93 | TLR7 (0.44) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999892 | 0.90 | TLR7 (0.49) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999901 | 0.89 | TLR7 (0.43) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999900 | 0.89 | TLR7 (0.48) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999898 | 0.88 | TLR7 (0.46) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999894 | 0.87 | ALDH1A1 (0.47) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999896 | 0.85 | TPSAB1 (0.46) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999893 | 0.83 | TLR7 (0.43) | TLR7LMNAPOLBNUDT1HRH2 | |
| SCHEMBL13999926 | 0.81 | TLR7 (0.53) | TLR7TLR8 | |
| SCHEMBL13999895 | 0.81 | TLR7 (0.43) | TLR7LMNAPOLBNUDT1HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306252-A1 | SULFONAMIDO ETHER SUBSTITUTED IMIDAZOQUINOLINES | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306252-A1 | SULFONAMIDO ETHER SUBSTITUTED IMIDAZOQUINOLINES | IFNG, IRF3, IL2 | TLR7 24/4885LMNA 4649/4885POLB 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.